Chair in Melanoma Biology appointed

The Institute’s Professor Peter Hersey has been appointed as the inaugural Chair in Melanoma Biology at the University of Sydney.

The Chair is the first of its kind in Australia and an exciting new initiative in the fight against melanoma. “It is a huge honour to be selected as the first holder of this position which elevates studies in melanoma to the highest academic level possible,” Professor Hersey said. The position is funded by the University’s Melanoma Foundation, comprised in part of a generous donation from the Cameron Family.

Professor Hersey has been working with Melanoma Institute Australia as a consultant Immunologist from his 

Our first year at the Poche Centre

On March 24 Melanoma Institute Australia celebrated its first anniversary at the Poche Centre. Funded by a generous $40 million gift from philanthropist Greg Poche AO, the Poche Centre is the largest single tumour facility in Australia.

For Chairman Reg Richardson AM, the move to the Poche Centre brought Melanoma Institute Australia one step closer to realising its vision.

Promising new drugs for melanoma

SYDNEY, Australia – 1 November 2010. Melanoma Institute Australia today said promising new clinical trial data detailing the progress of new targeted drug therapies to address the alarming rise of deadly melanoma skin cancers would be revealed at the 7th Annual Melanoma Research Congress and 4th Melanoma and Skin Cancer Centres Meeting in Sydney this weekend.

Dr Keith Flaherty from the Massachusetts General Hospital Cancer Centre will deliver the keynote speech on Thursday 4th November. He will present data from clinical studies of new drugs developed by Roche and Glaxo Smith Kline that target BRAF mutations, which occur in 50% of melanomas. These drugs